Cargando…
Rate control with intravenous diltiazem, verapamil, and metoprolol in acute atrial fibrillation with rapid ventricular rate
INTRODUCTION: Diltiazem is a preferred agent for rate control in atrial fibrillation due to its quick onset, minimal side effects, and low cost. Due to its intermittent national shortage since February 2018, the utilization of intravenous metoprolol and verapamil has increased. This study investigat...
Autores principales: | Medeiros, Tia, Bui, Vi, Almekdash, Mhd Hasan, Keesari, Rohali, Lee, Young R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155749/ https://www.ncbi.nlm.nih.gov/pubmed/34104435 http://dx.doi.org/10.1177/20503121211017756 |
Ejemplares similares
-
Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis
por: Sharda, Saurabh C., et al.
Publicado: (2022) -
Diltiazem Dosing Strategies in the Management of Atrial Fibrillation With Rapid Ventricular Rate
por: Bishop, James, et al.
Publicado: (2021) -
Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Kim, Minsoo, et al.
Publicado: (2019) -
A Systematic Review of Weight-Based Metoprolol for Acute Atrial Fibrillation with Rapid Ventricular Rate
por: Burum, Alexandra, et al.
Publicado: (2023) -
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)